Kapil Dhingra's Net Worth
$1.75 Million
Who is Kapil Dhingra?
Kapil Dhingra has an estimated net worth of $1.75 Million. This is based on reported shares across multiple companies, which include Replimune Group, Inc., Black Diamond Therapeutics, Inc., MICROMET, INC., FIVE PRIME THERAPEUTICS, INC., and CARGO Therapeutics, Inc..
SEC CIK
Kapil Dhingra's CIK is 0001456849
Past Insider Trading and Trends
2024 was Kapil Dhingra's most active year for acquiring shares with 4 total transactions. Kapil Dhingra's most active month to acquire stocks was the month of May. 2021 was Kapil Dhingra's most active year for disposing of shares, totalling 5 transactions. Kapil Dhingra's most active month to dispose stocks was the month of March. 2020 saw Kapil Dhingra paying a total of $70,000.00 for 76,500 shares, this is the most they've acquired in one year. In 2020 Kapil Dhingra cashed out on 80,000 shares for a total of $1,822,394.89, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Replimune Group, Inc. (REPL) Snapshot price: $10.88
InvestorKapil Dhingra used to own units in Common Stock but no longer holds any shares there. From 2018 to 2024 Kapil Dhingra acquired a total of 40,000 shares in Replimune Group, Inc. at a cost of $70,000.00, Kapil also disposed a total of 40,000 shares of Replimune Group, Inc. equalling to $1,822,394.89.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
$23.66 | -$1,752,394.89 |
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Black Diamond Therapeutics, Inc. (BDTX) Snapshot price: $5.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MICROMET, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
FIVE PRIME THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CARGO Therapeutics, Inc. (CRGX) Snapshot price: $18.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |